This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
This study aims to identify risk factors for conduction disturbances in such patients using a specific fluoroscopic cusp overlap (COL) technique.MethodsThis retrospective study analyzed AS patients who underwent TAVR with SEV from 2019 to 2022, excluding those needing pacemakers or valve-in-valve procedures.
BACKGROUND:A high permanent pacemaker implantation (PPI) risk remains a concern of self-expandable transcatheter aorticvalve implantation, despite the continued improvements in implantation methodology. There were no group differences in 30-day all-cause mortality (1.4% versus 0%;P=0.608).CONCLUSIONS:Our
Objectives To explore the ethnic differences in patients undergoing aorticvalve (AV) intervention for severe aortic stenosis (AS) in Leicestershire, UK. Results Of the 1231 SAVR and 815 TAVI performed, 6.5% were in ethnic minority patients, respectively.
Backgrounds Permanent pacemaker implantation (PPMI) is one of the greatest disadvantages of transcatheter aorticvalve implantation (TAVI). Methods We retrospectively analysed data from 745 consecutive patients who underwent TAVI for severe aortic stenosis from November 2013 to July 2022.
BACKGROUND:Data concerning the outcomes of transcatheter aorticvalve replacement in type 0 bicuspid aortic stenosis (AS) are scarce. Self-expanding transcatheter heart valves were used in the majority of patients (n=1160; 91.4%). In the matched population, differences in mortality (30 days: 4.2%
Procedure trends certainly suggest that we’ve entered the TAVR era, but a pair of new studies show that surgical aorticvalve replacement (SAVR) is a far better option for many younger and healthier patients who are increasingly seen as TAVR candidates. The proportion of SAVR patients increased in the <65yr patient group (26.2%
BACKGROUND:This study aimed to compare the incidence and prognostic implications of new-onset conduction disturbances after surgical aorticvalve replacement (SAVR) in patients with bicuspid aorticvalve (BAV) aortic stenosis (AS) versus patients with tricuspid aorticvalve (TAV) AS (ie, BAV-AS and TAV-AS, respectively).
Transcatheter aorticvalve implantation (TAVI) is a minimally invasive surgical procedure that has revolutionised the treatment of severe aortic stenosis (AS). It is a serious condition that can significantly impair quality of life and lead to fatal cardiovascular complications if left unmanaged.
BACKGROUND:The extent of cardiac damage has been shown to be associated with increased mortality, repeat hospitalization, and decreased quality of life after aorticvalve replacement (AVR). Patients were categorized into 5 groups (stages 04) based on their stage of cardiac damage in the year before AVR.
David Smith, Ayush Khurana, Aprim Youhana, Adrian Ionescu, Kissing Balloon “Valvuloplasty” of Obstructed Mechanical AorticValve: When You Are Running Out of Options, JACC: Case Reports,Volume 4, Issue 13, 2022, Pages 799-801, 2.Kandzari Balloon “Valvuloplasty” for Mechanical Valve Dysfunction.
Lp(a) is emerging as an important, yet under-recognized, potential risk factor for cardiovascular disease due to its ability to promote the development of plaques within artery walls, clot formation and aorticvalve calcification. 2022 Aug, 80 (9) 934946 Kronenberg F.
BackgroundAcute ischemic stroke complicates 2% to 3% of transcatheter aorticvalve replacements (TAVRs). This study aimed to identify the aortic anatomic correlates in patients after TAVR stroke.Methods and ResultsThis is a single‐center, retrospective study of patients who underwent TAVR at the Mayo Clinic between 2012 and 2022.
Background:Atherosclerotic cardiovascular disease (ASCVD) is highly prevalent in patients with severe aortic stenosis undergoing transcatheter aorticvalve replacement (TAVR). Circulation: Cardiovascular Interventions, Ahead of Print. Exposure of interest was PVD. Primary outcome was all-cause mortality.
Background: Symptomatic severe aortic stenosis (AS) remains undertreated with high resultant mortality despite increased growth and availability of aorticvalve replacement (AVR) since the advent of transcatheter therapies. The patient cohort had mean age of 7711 years, was 47% female, and had mean aorticvalve area 0.80.1
24: Joint American College of Cardiology/Journal of the American College of Cardiology Late-Breaking Clinical Trials (Session 402) Saturday, April 6 9:30 – 10:30 a.m. ET Murphy Ballroom 4 ACC.24 24 planners note that attendees can gain insights from key clinical trials presented at ACC.24
Patients with significant pulmonary oedema or aorticvalve (AV) closure during venoarterial extracorporeal membrane oxygenation (VA-ECMO) were randomized to early left ventricular (LV) unloading or conventional strategy groups (1:1). The primary endpoint was the rate of weaning from VA-ECMO during index admission.
Methods This study analyzed 2,771 publications related to patient management after valve replacement published in the Web of Science Core Collection database between January 1, 2013, and December 31, 2022. Transcatheter aorticvalve replacement was a current research hotspot, while anticoagulation management was a key area of interest.
Methods Electronic medical records were reviewed for preoperative, operative, and follow-up data of the patients who underwent septal myectomy using PEAK PlasmaBlade at our institute between January 2019 and December 2022. Results Twenty-nine patients underwent septal myectomy using the PEAK PlasmaBlade. mmHg at rest and 56.5 ± 34.9 mmHg
An Aortic Impella device, that is distal to the aorticvalve and devoid of LV-related issues. Epub 2022 Jul 25. The innovators and engineers of new-age mechanical assist systems could learn a few crucial insights from these unique and humble animal beings. Aalkjær C, Wang T. The cardiovascular challenges in giraffes.
Left ventricular afterload reduction is essential to decrease the trans-se ptal pressure gradient and thus decrease shunt volume, making a larger proportion of the blood flow from the left ventricle through the aorticvalve. I thought the presentation of today's case makes it worthwhile to review the data regarding this issue.
Intraoperative TEE noted "Type A aortic dissection arising 1.0 cm distal to the non-coronary cusp of the aorticvalve." Her dissection was repaired and her aorticvalve was resuspended. She was noted to have a blood-tinged pericardial effusion. I focus my comment on why I thought so.
Event 2023 STS Coding Workshop kchalko Tue, 11/15/2022 - 16:12 Event dates Feb 10–11, 2023 Location Virtual Registrants : To access the library of on-demand content, log into the STS Learning Center. Then go to “In Progress” courses on the dashboard or look in the “My Activities” tab. hours total) Joseph Turek, MD, Jeffrey P.
This next-generation surgical aortic tissue valve is designed to facilitate ease of use at implant and lifetime patient management. It’s an excellent choice for cardiac surgeons and their patients seeking an aorticvalve solution that can be fit for the future, right from the start. February 18–21, 2024.
This next-generation surgical aortic tissue valve is designed to facilitate ease of use at implant and lifetime patient management. It’s an excellent choice for cardiac surgeons and their patients seeking an aorticvalve solution that can be fit for the future, right from the start. February 18–21, 2024.
Objectives To evaluate the results of the inoperable and operable with aorticvalve endocarditis, focus on risk factors, significance, and management of destruction of the aortic annulus in aorticvalve endocarditis.
Transcatheter aorticvalve replacement (TAVR) has emerged as the preferred treatment for older patients suffering from severe aorticvalve stenosis, surpassing the annual patient count of those opting for surgical aorticvalve replacement. in 2019-2022. years, with 56% being women.
milla1cf Fri, 06/07/2024 - 14:50 June 7, 2024 — Medtronic today announced new data from the CoreValve Evolut Clinical Program , reinforcing the positive performance of the Evolut transcatheter aorticvalve replacement (TAVR) System compared to surgical aorticvalve replacement (SAVR) and other TAVR valves.
Objective A paucity of data exists on how transcatheter aorticvalve implantation (TAVI) practice has evolved in Ireland. This study sought to analyse temporal trends in patient demographics, procedural characteristics, and clinical outcomes at an Irish tertiary referral centre. mean Society of Thoracic Surgeons score 5.9±5.1).
In light of the growing number of patients undergoing transcatheter aorticvalve replacement (TAVR), there is an increasing demand for data regarding the management of failed TAVR procedures, including the possibility of a repeat TAVR intervention. No significant disparities were found in the rates of death at 30 days (4.7%
Objectives The management of severe aortic stenosis mandates consideration of aorticvalve intervention for symptomatic patients. However, for asymptomatic patients with severe aortic stenosis, recent randomised trials supported earlier intervention. to 0.96; I 2 15%).
As per Dr. Meyers — Given the context of a patient with known AFlutter since her aorticvalve repair — for which she had been taking the Flecainide but not the Metoprolol she was prescribed — ECG #2 almost certainly represented conversion of her AFlutter from 2:1 to 1:1 AV conduction. Did You Calculate Atrial and Ventricular Rates?
BackgroundMalnutrition status is an important predictor of prognosis in patients after aorticvalve replacement. However, the prognostic value of malnutrition status in patients with moderatetosevere aortic stenosis is unclear. Journal of the American Heart Association, Ahead of Print.
Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-Arterial Coronary Surgery: Ten Year Follow-up of One Million (..)
Program Designations Access and Publications (A&P) 1 Participant User File (PUF) 2 Task Force on Funded Research (TFR) 3 Special Projects 4 Adult Cardiac Surgery Database Lead Author Title Publication Date William Keeling 2 National Trends in Emergency Coronary Artery Bypass Grafting European Journal of Cardiothoracic Surgery October 2023 Jake (..)
IntroductionTranscatheter aorticvalve replacement (TAVR), alternatively termed transcatheter aorticvalve implantation (TAVI), represents a seminal advancement in cardiovascular interventions by obviating the necessity for open-heart surgery traditionally associated with surgical aorticvalve replacement (SAVR).
in patients with native aortic stenosis (p<0.01) with a similar percentage of females in both groups (42% vs. 49.3%, p=0.18). p=0.01) independently associated with elevated gradients after ViV-TAVR.ConclusionViV-TAVR for treatment of degenerated bioprostheses improves aorticvalve function. years (IQR 70.084.0) IQR 77.085.0)
The patient was finally weaned to room air on day 4 and taken for a CT scan to evaluate the possibility of aorticvalve replacement. The scan showed a bicuspid aorticvalve with severe stenosis and coronary artery disease. --increasing stenosis, ischemia, volume changes, increased blood pressure, atrial fibrillation, etc.)
Larger shunt volume means less blood exiting the left ventricle through the aorticvalve and lower cardiac output. The pressure gradient in this case was significant indicating that the defect is rather small. The larger the size of the defect the larger the shunt. Cardiology , 114. link] [5] Vega, J. Salinas, G. 2018, July 30).
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
52 
Let's personalize your content